Idorsia Ltd banner

Intrinsic Value

Is IDIA undervalued or overvalued?

See the intrinsic value estimate for Idorsia Ltd and find out whether today’s valuation is cheap or expensive by its own historical standards.

Do our valuations actually work? See backtest results .

IDIA Intrinsic Value
LOCKED
Unlock
Today vs. history

IDIA looks overvalued.
But is it expensive by its own standards?

See how today’s valuation compares with IDIA’s past valuations and how the stock performed after similar periods.

See what happened next Free account required
Monitor IDIA
Get notified when the price drops
Track Buy Zone
20% below Intrinsic Value
Get notified when the price drops into your buy zone
Current Price CHf4.17
Intrinsic Value Locked
Margin of Safety 20% Locked
Or choose another margin of safety
0% below Intrinsic Value
10% below Intrinsic Value
30% below Intrinsic Value
40% below Intrinsic Value
50% below Intrinsic Value
Custom
Alternatives to IDIA

Fundamental Analysis

What Idorsia Does

Biotechnology Health Care

Idorsia is a Swiss biopharmaceutical company that discovers and develops prescription medicines. It focuses on diseases where patients need new treatment options, especially sleep disorders, high blood pressure, and some immune and nervous system conditions. The company’s work is centered on creating new drug candidates, testing them in clinical trials, and getting them approved for sale.

Headquarters
Switzerland CH
Employees
456
IPO date
Jun 16, 2017
Read the full company overview
View Company Overview
Financials
Efficiency

Earnings Waterfall
Idorsia Ltd

Wall St Price Targets

Capital Returns

Buyback Yield
LOCKED
Debt Paydown Yield
LOCKED

Competitive Landscape

What is the Intrinsic Value of one IDIA stock?

The intrinsic value for Idorsia Ltd (IDIA) under the Base Case is hidden CHF.

Is IDIA stock undervalued or overvalued?

Compared with the current market price of 4.17 CHF, the stock appears hidden.

Back to Top